Publications by authors named "Christopher Maddage"

Claim this Profile
C
Characterization of human cancer xenografts in humanized mice.
Jonathan Rios-Doria, Christina Stevens, Christopher Maddage, Kerri Lasky, Holly K Koblish

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity.
Xin Cheng, Jing Li, Keigo Tanaka, Utpal Majumder, Andrew Z Milinichik, Christopher J Maddage

Mol Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.
JianMin Lin, Jared L Spidel, Christopher J Maddage, Katherine A Rybinski, Rina P Kennedy

Cancer Biol Ther· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis